HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: H2O Plus

This article was originally published in The Rose Sheet

Executive Summary

H2O Plus: Appoints Kim Delsing to president and CEO of the specialty toiletries retailer, the Chicago-based firm announced May 24. Delsing, formerly president of Elizabeth Arden, joins H2O Plus' current chairman John Melk, exec VP and creative director Cindy Melk and recently appointed VP-Merchandising and Marketing Jamie Delsing to form the management team of H2O Plus' Gulfstream Partners division. The newly established Gulfstream Partners was created to "move the existing H2O Plus business to the next level" by "explor[ing] many diverse opportunities in the personal products field," the company said. Delsing left her position at Arden and her post as Unilever prestige personal products chairman in August, one year after assuming the top slot at the cosmetics company ("The Rose Sheet" Aug. 21, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002840

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel